Treatment success rate for patients treated for MDR-TB in South-East Asia (WHO region)
South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB was 77.0% in 2022. ▲ Rising
Latest (2022)
77.0%
Change on year
up 5.5%
Rank
2nd
of 11 groups
All-time high
77.0%
in 2022
All-time low
48.0%
in 2012
Years of data
17
2006–2022
Treatment success rate for patients treated for MDR-TB in South-East Asia (WHO region), 2006–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in South-East Asia (WHO region) is 77.0%, measured in 2022. That is the highest value across all 17 years on record.
The figure is up 5.5% on the previous year and up 60.4% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in South-East Asia (WHO region) peaked at 77.0% in 2022 and was at its lowest, 48.0%, in 2012.
The long-run direction has been consistently rising across the 17 years of available data.
Treatment success rate for patients treated for MDR-TB in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 57.0% | — |
| 2007 | 71.0% | +24.6% |
| 2008 | 60.0% | -15.5% |
| 2009 | 54.0% | -10.0% |
| 2010 | 55.0% | +1.9% |
| 2011 | 53.0% | -3.6% |
| 2012 | 48.0% | -9.4% |
| 2013 | 49.0% | +2.1% |
| 2014 | 50.0% | +2.0% |
| 2015 | 50.0% | +0.0% |
| 2016 | 52.0% | +4.0% |
| 2017 | 53.0% | +1.9% |
| 2018 | 58.0% | +9.4% |
| 2019 | 59.0% | +1.7% |
| 2020 | 69.0% | +16.9% |
| 2021 | 73.0% | +5.8% |
| 2022 | 77.0% | +5.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.5% | 54.0% | 71.0% | 4 |
| 2010s | 52.7% | 48.0% | 59.0% | 10 |
| 2020s | 73.0% | 69.0% | 77.0% | 3 |
Countries ranked near South-East Asia (WHO region)
- 1 New Zealand 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Jordan 100.0% compare
- 1 Serbia 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Belize 100.0% compare
- 1 Macau, China 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Kiribati 100.0% compare
- 1 Cape Verde 100.0% compare
- 1 Puerto Rico 100.0% compare
- 1 Costa Rica 100.0% compare
- 1 Micronesia, Federated States of 100.0% compare
- 1 United Arab Emirates 100.0% compare
More health data for South-East Asia (WHO region)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in South-East Asia (WHO region)?
- Treatment success rate for patients treated for mdr-tb in South-East Asia (WHO region) was 77.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in South-East Asia (WHO region)?
- The highest recorded value was 77.0% in 2022.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in South-East Asia (WHO region)?
- The lowest recorded value was 48.0% in 2012.
- How does South-East Asia (WHO region) rank for treatment success rate for patients treated for mdr-tb?
- South-East Asia (WHO region) ranks 2nd out of 11 groups with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 60.4%. The long-run trend across the full record is rising.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).